These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease. Lee MS; Kim HS; Cho EK; Lim JH; Rinne JO Neurology; 2002 Feb; 58(4):564-7. PubMed ID: 11865133 [TBL] [Abstract][Full Text] [Related]
15. [Treatment in Parkinson disease]. Takáts A Orv Hetil; 2004 Apr; 145(15):833-4. PubMed ID: 15188639 [No Abstract] [Full Text] [Related]
16. Clinical advantages of COMT inhibition with entacapone - a review. Gordin A; Kaakkola S; Teräväinen H J Neural Transm (Vienna); 2004 Oct; 111(10-11):1343-63. PubMed ID: 15340869 [TBL] [Abstract][Full Text] [Related]
17. Microplate screening assay to identify inhibitors of human catechol-O-methyltransferase. Kurkela M; Siiskonen A; Finel M; Tammela P; Taskinen J; Vuorela P Anal Biochem; 2004 Aug; 331(1):198-200. PubMed ID: 15246016 [No Abstract] [Full Text] [Related]